Inflammatory bowel disease (IBD) is a broad term that refers to a variety of conditions characterised by chronic inflammation of the digestive tract. Severe diarrhoea, abdominal pain, exhaustion, and weight loss are all symptoms of the condition.
The Inflammatory bowel disease market is being driven by an increase in the incidence of IBD and an increase in the use of anti-inflammatory medications. In addition, the market is expected to rise due to a strong forthcoming pipeline of IBD medications. However, the adverse effects of these treatments on the body of the patient limit market expansion. Market growth will be aided by the development of biosimilars for existing pharmaceuticals, as well as growth possibilities in Asia-Pacific and Latin America.
Read more @ https://cmilatestinsights.blogspot.com/2022/01/inflammatory-bowel-disease-market-size.html
